Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03545893 · ClinicalTrials.gov registry record · Phase 4
Overnight Pain Treatment Investigating Opioids vs. Nonopioids
A Phase 4 study of Abortion, Second Trimester, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT03545893: Completed Phase 4 study of Abortion, Second Trimester, sponsored by University of Pennsylvania.
NCT03545893 is a Phase 4 study of Abortion, Second Trimester that has completed, run by University of Pennsylvania. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03545893, a Phase 4 study of Abortion, Second Trimester, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare maximum pain scores between patients seeking induced abortion and requiring cervical preparation with osmotic dilators. Patients will be randomized to receive prescription for ibuprofen alone or to receive prescription for ibuprofen + oxycodone for overnight pain management after cervical preparation with osmotic dilators. Data collected in-person and through a text-messaging platform.
Conditions Studied
Interventions
- DRUG Ibuprofen 600 mg
- DRUG OxyCODONE 5 Mg Oral Tablet
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2019-02-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03545893
The ClinicalTrials.gov registry entry for NCT03545893 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abortion, Second Trimester appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen 600 mg is the first listed.
NCT03545893 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03545893 about?
NCT03545893 is a clinical study titled "Overnight Pain Treatment Investigating Opioids vs. Nonopioids". The purpose of this study is to compare maximum pain scores between patients seeking induced abortion and requiring cervical preparation with osmotic dilators. Patients will be randomized to receive prescription for ibuprofen alone or to receive prescription for ibuprofen + oxycodone for overnight p...
What is the current status of trial NCT03545893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2018-06-19. Estimated completion is 2019-02-07.
What conditions does trial NCT03545893 study?
This clinical trial studies the following conditions: Abortion, Second Trimester.
What interventions are being tested in trial NCT03545893?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), OxyCODONE 5 Mg Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT03545893?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03545893 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abortion, Second Trimester
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.